Invention Grant
- Patent Title: Retroviral transduction using poloxamers
-
Application No.: US14381586Application Date: 2013-02-28
-
Publication No.: US09771599B2Publication Date: 2017-09-26
- Inventor: Natasa Anastasov , Ines Höfig , Christian Thirion
- Applicant: HELMHOLTZ ZENTRUM MÜNCHEN-DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH) , SIRION BIOTECH GMBH
- Agency: Perdue IP Law, APC
- Priority: EP12157461 20120229
- International Application: PCT/EP2013/054104 WO 20130228
- International Announcement: WO2013/127964 WO 20130906
- Main IPC: C12N15/86
- IPC: C12N15/86 ; C12N15/867 ; A61K48/00

Abstract:
The present invention relates to a method for transducing a target cell, the method comprising the step of contacting a target cell with a retroviral vector and a poloxamer having a molecular weight of 12.8 kDa to about 15 kDa. Further, the invention relates to the use of a poloxamer as defined herein, optionally in combination with a polycationic substance as defined herein, for transducing a target cell with a retroviral vector and a kit comprising a retroviral vector, a poloxamer as defined herein and, optionally, instructions for use.
Public/Granted literature
- US20150064788A1 RETROVIRAL TRANSDUCTION USING POLOXAMERS Public/Granted day:2015-03-05
Information query
IPC分类: